Published in Women's Health Weekly, April 17th, 2006
Researchers at the San Francisco VA Medical Center sought "to determine whether baseline serum uric acid (UA) levels and estrogen-progestin (E + P)associated change in serum UA in postmenopausal women with coronary disease are associated with recurrent coronary heart disease (CHD) events."
J.A. Simon and colleagues described their study: "2763 postmenopausal women enrolled in the Heart and Estrogen-Progestin Replacement Study (HERS) were randomly assigned to take conjugated E + P or placebo in a secondary CHD prevention study. The primary outcome for these analyses was nonfatal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.